VANTABIOHealthcare Research, Analytics & Technology
Vanta Bioscience Ltd — PE Ratio & Valuation Analysis
₹15.15
-10.72%
Current P/EN/AxPrice to earnings
Industry P/E45.95xSector average
✅
100.0% Discount to Industry
VANTABIO P/E N/Ax vs sector avg 45.95x
💡
Understanding Vanta Bioscience Ltd Valuation
Vanta Bioscience Ltd (VANTABIO) currently trades at N/Ax earnings. The Healthcare Research, Analytics & Technology sector average PE is 45.95x. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-37.24%
Dividend Yield
0.00%
More on Vanta Bioscience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.